Gary Bourgeault
Long only, research analyst, portfolio strategy, media

It's Time To Love Or Hate Accretive Health, Inc.

Accretive Health, Inc. (AH) is a hated stock today, as just about everything that could go wrong for this high-flyer has gone wrong, and investors still await the outcome of the incorrect booking of its revenues for at least the last nine quarters, saying it will have to restate all its quarterly financial statements back to the second quarter of 2010. It has also warned investors they can't rely on any of the financial statements it released for the 2009, 2010 and 2011 fiscal years.

Accretive said in March it was "still assessing whether restatement will be required for prior periods." So far there has been no communication or indication of how the errors were committed.

Concerning the restatements, Accretive...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details